Locally advanced head and neck cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

• Publication date

  2013-05-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/EdBook_AM.2013.33.237PMID 23714512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and scientific impact of human papillomavirus on head and neck cancer.

  2014cited by this paper
• Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.

  2013cited by this paper
• Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.

  2012cited by this paper
• Transoral laser microsurgery as primary treatment for advanced‐stage oropharyngeal cancer: A united states multicenter study

  2011cited by this paper
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.

  2011cited by this paper
• Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

  2011cited by this paper
• Larynx preservation clinical trial design: summary of key recommendations of a consensus panel.

  2010cited by this paper
• Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: A subset analysis of the university of pennsylvania transoral robotic surgery trial

  2010cited by this paper
• Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.

  2010cited by this paper
• GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas.

  2009cited by this paper
• Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.

  2009cited by this paper
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

  2009cited by this paper
• The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx

  2009cited by this paper
• A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer.

  2008cited by this paper
• Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

  2007cited by this paper
• Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

  2007cited by this paper
• Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

  2006cited by this paper
• Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.

  2006cited by this paper
• Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors.

  2005cited by this paper
• The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.

  2005cited by this paper
• Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer.

  2004cited by this paper
• Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.

  2003cited by this paper
• Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

  2003cited by this paper
• A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.

  2001cited by this paper
• A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.

  2000cited by this paper
• Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

  2000cited by this paper
• The CHART regimen and morbidity.

  1999cited by this paper
• Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing.

  1998cited by this paper
• A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.

  1997cited by this paper
• Fast-neutron therapy in advanced head and neck cancer: a collaborative international randomized trial.

  1995cited by this paper
• Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council.

  1993cited by this paper
• Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

  1991cited by this paper
• Design principles and clinical possibilities with a new generation of radiation therapy equipment. A review.

  1987cited by this paper

• A systematic review and network meta-analysis of therapies for locally advanced head and neck squamous cell carcinoma with different HPV status

  2025cites this paper
• Diffusion-Weighted MRI for Recurrent/Persistent Head and Neck Squamous-Cell Carcinoma After Radiotherapy: Systematic Review and Meta-Analysis.

  2024cites this paper
• Induction chemotherapy in locally advanced head and neck cancers, is there a best choice?

  2023cites this paper
• NTF2 Upregulation in HNSCC: a Predictive Marker and Potential Therapeutic Target Associated With Immune Infiltration

  2022cites this paper
• Probiotics for the Management of Oral Mucositis: An Interpretive Review of Current Evidence

  2022cites this paper
• Survival Outcomes and Factors Affecting Survival in Resectable Locally Advanced Oral Squamous Cell Carcinoma

  2022cites this paper
• A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma.

  2021cites this paper
• Novel insights into hyperthermia’s therapeutic effectiveness in treating malignant melanoma

  2018cites this paper
• DNA methylation biomarkers for head and neck squamous cell carcinoma

  2018cites this paper
• The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies

  2016cites this paper
• Neoadjuvant Chemotherapy for Locally Advanced Squamous Carcinoma of Oral Cavity: a Pilot Study.

  2015cites this paper
• Clinical and scientific impact of human papillomavirus on head and neck cancer.

  2014cites this paper